Robert McNeill
Internal Medicine · Salisbury, NCNPI 1154317170
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,898 of the $4,439 with a category attached, or 65.3%. 11 manufacturers reported payments, led by UCB Biosciences Inc. at 36.2% of the total. Reporting peaked in 2019 at $4,129 and has fallen 99.8% since, to $7 in 2021. Among internal medicine clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 36 payments — averaging $123.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB Biosciences Inc.$2K
- Novo Nordisk AS$2K
- Novo Nordisk$577
- Pfizer$195
- Amgen$165
- Johnson & Johnson$86
- plus $234 from 5 others
Across 386 payments — averaging $5710.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$1.2M
- Novo Nordisk AS$529K
- Amgen$245K
- Orasure Technologies Inc.$145K
- Pfizer$58K
- AstraZeneca$23K
- plus $25K from 5 others
What the payments were for
- Travel & lodging$2,89865%
- Food & beverage$1,51034%
- Education$311%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB Biosciences Inc. | 8 | $1,608 |
| Novo Nordisk AS | 4 | $1,575 |
| Novo Nordisk | 7 | $577 |
| Pfizer | 9 | $195 |
| Amgen | 2 | $165 |
| Johnson & Johnson | 1 | $86 |
| AstraZeneca | 1 | $83 |
| Sanofi-aventis U.S. LLC | 1 | $80 |
| Portola Pharmaceuticals, LLC | 1 | $33 |
| Acadia Pharmaceuticals Inc | 1 | $22 |
| Astellas Pharma US Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ozempic$1,575
How this compares
$4,439 in reported general payments places this provider in the 90th percentile of 3,302 internal medicine providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanumetSitagliptin Phos/Metformin Hcl | 14 | $7,961 |
| Metoprolol Succinate | 14 | $294 |
| Omeprazole | 14 | $294 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Salisbury
- Nirmish ShahDurham$862K
- Eugene WrightFayetteville$839K
- Saad UsmaniCharlotte$551K
- Bhakti PaulRaleigh$536K
- Mary KlotmanDurham$478K
- Manesh PatelDurham$435K
- Millie LongChapel Hill$374K
- Marc JohnsonCharlotte$342K
- Christina CraterRaleigh$330K
- Jamy ArdWinston Salem$293K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.